medicalxpress.com /1 month ago

Half-matched bone marrow transplant expands options for children with severe aplastic anemia

Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins Children's Center report that bone marrow transplant using half-matched family donors a...

Read source
bioengineer.org /3 weeks ago

Regenerating Bone Marrow Gives Transplanted Stem Cells a Lasting Boost in Mice

A mouse study found that hematopoietic stem cells engrafted during active bone marrow regeneration showed superior long-term reconstitution compared with cells engrafted after myel...

Read source
kmbc.com /1 month ago

11-year-old celebrates life-saving bone marrow transplant with help from older brother

Peyton Stewart, 11, received a life-saving bone marrow transplant from his older brother after being diagnosed with a rare genetic mutation.

Read source
genengnews.com /4 days ago

Genetic Barcoding Reveals How Pre-Bone Marrow Transplant Conditioning Impacts Immune System Regeneration

Researchers used genetic barcoding to track human blood-forming stem and progenitor cells transplanted into mice, revealing how the different cell types regenerate the blood and im...

Read source
medicalxpress.com /1 month ago

Earlier stem cell transplants may improve survival in rare inherited bone marrow disorder

More than 90% of children born with the rare bone marrow condition Shwachman-Diamond syndrome (SDS) survive beyond age 20. But fewer than 30% live beyond age 50. Long-term survival...

Read source
wlky.com /1 month ago

11-year-old celebrates life-saving bone marrow transplant with help from older brother

Peyton Stewart, 11, received a life-saving bone marrow transplant from his older brother after being diagnosed with a rare genetic mutation.

Read source
medcitynews.com /4 days ago

Marrow Therapeutics Unveils $173M for ‘Trojan Horse’ Delivery of Blood Disorder Drugs

Sickle cell disease and beta thalassemia are the startup’s lead indications. While gene therapies are available for both blood disorders, Marrow executives say manufacturing and do...

Read source
timesofindia.indiatimes.com /1 month ago

Stanford blood cancer transplant therapy reaches first commercial patient

In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative...

Read source
biopharmadive.com /5 days ago

Marrow sets out to challenge genetic medicines for severe blood diseases

Armed with $173 million in venture funding, the startup is developing what it’s positioning as a more accessible alternative to gene therapy and gene editing treatments for sickle...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.